Filing metadata

Accession number
0000950170-24-076188
Form type
Form 4
Filer
Damora Therapeutics, Inc.
CIK
CIK 1800315
Filed
Jun 21, 2024
Reporting period
Jun 20, 2024
Description
Insider transaction

Explore SEC Filings Hub